Cannaisseur Group Inc.
Cannaisseur Group Inc. is a U.S.-based micro-cap company formed in December 2020 that acquired a controlling 51% interest in Atlanta CBD Inc., which operates under the Inno Medicinals trade name. The business started in hemp cultivation, extraction, manufacturing, distribution, and CBD retail, and has since shifted toward health and wellness products centered on CBD-related offerings. Today, the company says its only operating assets and activities are tied to Atlanta CBD’s retail store in Atlanta, Georgia and its e-commerce channel. Management also describes the company as being in an early-stage expansion phase, with operations dependent on external financing and continued development of the product line.
Fiscal year 2024 · change from previous year
Development 2022–2024
Business
Share of revenueConsumer-facing CBD-related and hemp-derived products sold through retail and online channels.
Broader wellness offerings the company says it is transitioning toward beyond core CBD items.
Customers
The company sells directly to consumers who buy CBD-related products for wellness, relaxation, and general self-care use. Its customer base includes walk-in shoppers at the Atlanta retail location and online buyers placing orders through the website. Because the business is still concentrated in a single operating subsidiary and a single retail footprint, customer demand is tied closely to local traffic, e-commerce conversion, and consumer interest in hemp-derived wellness products. The company also appears exposed to price-sensitive buyers in a competitive category where product differentiation and trust matter.
Customers visiting the Atlanta store to buy CBD-related products at point of sale for immediate use and convenience.
Online buyers who purchase products through the website and value convenience, product availability, and direct shipping.
Consumers attracted to the company's broader wellness positioning and CBD-related product assortment.
Customers who return for familiar hemp-derived products and consistent product quality.
Strategy
Management’s near-term priority is to keep the business funded while supporting day-to-day operations at Atlanta CBD and preserving the company as a going concern. The company expects to raise capital from private investors and investment firms and is also seeking non-recourse debt to support working capital and operating expenses. Strategically, it wants to continue offering smaller investment opportunities now, with the longer-term goal of raising larger amounts of capital to expand operations. It also intends to broaden the product mix toward health and wellness offerings, which is meant to align the brand with a wider consumer market than CBD alone.
The company has limited operating scale and a going-concern warning, so funding is necessary to maintain operations and execute its plan.
The company currently relies on a single operating subsidiary, so maintaining sales and execution there is essential.
A wider product set could reduce dependence on a narrow CBD-only proposition and improve market relevance.
Geography
The company’s operating footprint is highly concentrated in Atlanta, Georgia, where Atlanta CBD runs its retail location and manages day-to-day operations. It also sells through e-commerce, which extends reach beyond the local store but remains tied to the same operating base. The business is U.S.-focused and does not disclose meaningful international operations in the provided materials. This concentration means performance depends heavily on the Atlanta market, U.S. consumer demand for CBD products, and the regulatory environment for hemp-derived goods.
Risks
The company faces substantial going-concern and liquidity risk because it has limited operating history, negative working capital, and depends on external financing to continue operations. Its business is concentrated in a single retail location and one operating subsidiary, which increases exposure to local demand swings, execution issues, and any disruption at Atlanta CBD. The CBD and hemp sector also carries regulatory risk, since product legality, labeling, and retail rules can change and vary by jurisdiction. Competition is intense and consumer demand can be volatile, while macroeconomic pressure such as inflation, higher interest rates, and recession risk can reduce discretionary spending on wellness products and make capital harder to raise.
The company disclosed substantial doubt about its ability to continue as a going concern and says it needs additional capital to fund operations.
Exposure: Corporate liquidity and operating continuity
Current operations consist only of the 51% interest in Atlanta CBD, making the business highly dependent on one subsidiary and one retail footprint.
Exposure: Revenue continuity and execution
The company sells hemp-derived and CBD-related products, which are subject to evolving federal and state rules.
Management cites an intense competitive environment and potential declines in consumer spending on its offerings.
Exposure: Sales volume and pricing
Inflation, higher interest rates, and recession risk can reduce discretionary spending and make financing more difficult.
Exposure: Customer demand and capital access
Accounting
Judgemental itemsSales are recognized when the product is purchased in store or when the online transaction settles, so quarter-end timing can affect reported revenue.
Impact: Can create volatility around shipment and payment cutoffs
Inventory is reviewed for market declines and write-downs are charged to cost of goods sold.
Impact: Can reduce gross margin and earnings if product values fall
The company’s only operating assets are tied to its 51% interest in Atlanta CBD, so consolidation judgments are central to the financial statements.
Impact: Determines how operating results and assets are presented
Management disclosed substantial doubt about continuing operations without additional financing.
Impact: Important for liquidity analysis and balance sheet interpretation
Similar listed companies
Publicly listed companies with a comparable business focus.
Target Group Inc.
CBDY · Medicinal Chemicals & Botanical Products
cbdMD, Inc.
YCBD · Perfumes, Cosmetics & Other Toilet Preparations
Cannapharmarx, Inc.
CPMD · Pharmaceutical Preparations
Cannabist Co Holdings Inc.
Agricultural Production-Crops
Cannabist Co Holdings Inc., formerly Columbia Care, is a U.S.
Canopy Growth Corp
CGC · Medicinal Chemicals & Botanical Products
Canopy Growth Corp is a cannabis and hemp company built around medical cannabis brands, vaporizers, and a portfolio of U.S.
CV Sciences, Inc.
CVSI · Pharmaceutical Preparations
Last updated: 24/09/2026